Biosign Technologies (BITKF) 0.0010 $BITKF
Biosign sells IBL Internet Business Logic Inc. Assets
CNW Group - Mon Aug 03, 10:57PM CDT
Biosign Technologies Inc (TSXV: BIO) ("Biosign" or the "Company"
announces that it has completed the sale of the business assets of wholly-owned subsidiary IBL Internet Business Logic Inc. to Quindell Services Inc. for a total purchase price of $2,500,000 which was paid in cash on closing. In conjunction with this transaction, all term loans plus interest payable by Biosign to Quindell Solutions Inc. have been forgiven to settle outstanding obligations amongst the parties.
BIO.VN: 0.005 (unch)
Biosign Announces Results of Shareholders Meeting
CNW Group - Wed May 06, 7:46PM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company" announces that it held an annual and special meeting of shareholders on May 5, 2015 where all of the items of business of the Company were approved, including:
BIO.VN: 0.005 (unch)
Biosign withdraws from acquisition of QLINE Solutions Inc.
CNW Group - Mon Jan 26, 6:16PM CST
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company" announced its Board of Directors has decided to withdraw from the acquisition of QLINE Solutions Inc. ("QLINE". The Company had executed a Share Purchase Agreement under which Biosign acquired 100% of the issued and outstanding shares of QLINE for a total price of $3.03 million including $830,000 to be paid in cash and the issuance of 44,000,000 common shares of Biosign at an ascribed value of $0.05 per share. Only $30,000 of the cash portion has been paid which will be retained by the sellers and all 44,000,000 shares held in trust will be returned to Biosign for cancellation.
BIO.VN: 0.005 (unch)
Biosign Secures License Sale with the Release of an Enterprise Version of its Clinic Management Software
CNW Group - Tue Jan 20, 6:57AM CST
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company" is pleased to announce that it has signed an initial one year user-based network license agreement with a substantial multi-national corporation, consisting of a large network of physiotherapy, paramedical and rehab clinics and an associated technology services group. Under this contract Biosign will host the new Enterprise Version of its cloud-based ClinicServer practice management solution. The release of the Enterprise Version will significantly expand the market for the ClinicServer practice management solution. This innovative cloud solution will empower our new customer to manage its complex multi-jurisdictional clinical operations from a centralized and unified technology base. Use of this Enterprise Version will substantially increase their operational efficiencies and also facilitate a new level of electronic payment processing into their expanding network of clinics. The customer has over 1500 clinics in its group of companies and our solution is currently being rolled-out to the North American division over the next two months.
BIO.VN: 0.005 (unch)
Biosign restructures demand loans
CNW Group - Mon Jan 05, 7:31AM CST
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company" announces that the demand loans payable to Quindell Solutions Inc. ("Quindell" totalling $6.8 million plus all accrued interest of circa $180,000 ("Accrued Interest" have been converted to a loan repayable over a period of 5 years ("Term Loan". The Term Loan accrues interest at the rate of 2% per annum above prime rate.
BIO.VN: 0.005 (unch)
Biosign closes acquisition of QLINE Solutions Inc.
CNW Group - Tue Nov 04, 4:00PM CST
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company" announces that it has formally closed the acquisition of 100% of the issued and outstanding shares of Peterborough, Ontario based QLINE Solutions Inc. ("QLINE". The Company announced on January 6, 2014, that the parties had executed a Share Purchase Agreement under which Biosign agreed to acquire 100% of QLINE for a total price of $3 million.
BIO.VN: 0.005 (unch)
Biosign sells IBL Internet Business Logic Inc. Assets
CNW Group - Mon Aug 03, 10:57PM CDT
Biosign Technologies Inc (TSXV: BIO) ("Biosign" or the "Company"
announces that it has completed the sale of the business assets of wholly-owned subsidiary IBL Internet Business Logic Inc. to Quindell Services Inc. for a total purchase price of $2,500,000 which was paid in cash on closing. In conjunction with this transaction, all term loans plus interest payable by Biosign to Quindell Solutions Inc. have been forgiven to settle outstanding obligations amongst the parties. BIO.VN: 0.005 (unch)
Biosign Announces Results of Shareholders Meeting
CNW Group - Wed May 06, 7:46PM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company"
announces that it held an annual and special meeting of shareholders on May 5, 2015 where all of the items of business of the Company were approved, including: BIO.VN: 0.005 (unch)
Biosign withdraws from acquisition of QLINE Solutions Inc.
CNW Group - Mon Jan 26, 6:16PM CST
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company"
announced its Board of Directors has decided to withdraw from the acquisition of QLINE Solutions Inc. ("QLINE". The Company had executed a Share Purchase Agreement under which Biosign acquired 100% of the issued and outstanding shares of QLINE for a total price of $3.03 million including $830,000 to be paid in cash and the issuance of 44,000,000 common shares of Biosign at an ascribed value of $0.05 per share. Only $30,000 of the cash portion has been paid which will be retained by the sellers and all 44,000,000 shares held in trust will be returned to Biosign for cancellation. BIO.VN: 0.005 (unch)
Biosign Secures License Sale with the Release of an Enterprise Version of its Clinic Management Software
CNW Group - Tue Jan 20, 6:57AM CST
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company"
is pleased to announce that it has signed an initial one year user-based network license agreement with a substantial multi-national corporation, consisting of a large network of physiotherapy, paramedical and rehab clinics and an associated technology services group. Under this contract Biosign will host the new Enterprise Version of its cloud-based ClinicServer practice management solution. The release of the Enterprise Version will significantly expand the market for the ClinicServer practice management solution. This innovative cloud solution will empower our new customer to manage its complex multi-jurisdictional clinical operations from a centralized and unified technology base. Use of this Enterprise Version will substantially increase their operational efficiencies and also facilitate a new level of electronic payment processing into their expanding network of clinics. The customer has over 1500 clinics in its group of companies and our solution is currently being rolled-out to the North American division over the next two months. BIO.VN: 0.005 (unch)
Biosign restructures demand loans
CNW Group - Mon Jan 05, 7:31AM CST
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company"
announces that the demand loans payable to Quindell Solutions Inc. ("Quindell" totalling $6.8 million plus all accrued interest of circa $180,000 ("Accrued Interest" have been converted to a loan repayable over a period of 5 years ("Term Loan". The Term Loan accrues interest at the rate of 2% per annum above prime rate. BIO.VN: 0.005 (unch)
Biosign closes acquisition of QLINE Solutions Inc.
CNW Group - Tue Nov 04, 4:00PM CST
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company"
announces that it has formally closed the acquisition of 100% of the issued and outstanding shares of Peterborough, Ontario based QLINE Solutions Inc. ("QLINE". The Company announced on January 6, 2014, that the parties had executed a Share Purchase Agreement under which Biosign agreed to acquire 100% of QLINE for a total price of $3 million. BIO.VN: 0.005 (unch)
